Euro-Med Laboratories Phil., Inc. Announces Consolidated Earnings Results for the Year Ended December 31, 2018
April 15, 2019 at 03:04 am EDT
Share
Euro-Med Laboratories Phil., Inc. announced consolidated earnings results for the year ended December 31, 2018. For the year, the company reported revenues of PHP 1,928,090,714 against PHP 1,788,026,815 a year ago. Net income after tax was PHP 373,911,790 against PHP 345,200,402 a year ago. Basic earnings per share were per share PHP 0.09 against PHP 0.08 a year ago.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
EURO-MED LABORATORIES PHIL., INC. 
